Paid Clinical Trials Bellevue

Discover 650 paid clinical trials in Bellevue, Nebraska. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 650

Smart Checklist Implementation for Pediatric Tracheal Intubations in the ICU- Multicenter StudySmart Checklist Implementation for Pediatric Tracheal Intubations in the ICU- Multicenter Study

Recruiting

Sponsor:

Children's Hospital of Philadelphia

Location:

Omaha NE, Little Rock AR, Akron OH, Atlanta GAshow 2 more

Code:

NCT06085326

Conditions

Intubation Complication

Eligibility Criteria

Sex: All

Age: 0 - 19

Healthy Volunteers: Not accepted

Interventions

Smart Checklist

ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)

Recruiting

PHASE3

Sponsor:

Chimerix

Location:

Omaha NE, Iowa City IA, Rochester MN, Minneapolis MNshow 53 more

Code:

NCT05580562

Conditions

H3 K27M

Glioma

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Dordaviprone (ONC201)

Dordaviprone (ONC201) + Placebo

Placebo

A Study Comparing GLIADEL to Stereotactic Radiosurgery in Metastatic Brain DiseaseA Study Comparing GLIADEL to Stereotactic Radiosurgery in Metastatic Brain Disease

Recruiting

PHASE2

Sponsor:

University of Nebraska

Location:

Omaha NE, Detroit MI

Code:

NCT04222062

Conditions

Brain Tumor - Metastatic

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Carmustine 7.7Mg Wafer

DALY II USA/ MB-CART2019.1 for DLBCLDALY II USA/ MB-CART2019.1 for DLBCL

Recruiting

PHASE2

Sponsor:

Miltenyi Biomedicine GmbH

Location:

Omaha NE, Westwood KS, Rochester MN, Chicago ILshow 18 more

Code:

NCT04792489

Conditions

Refractory Diffuse Large B Cell Lymphoma (DLBCL)

Relapsed Diffuse Large B Cell Lymphoma

High Grade B-cell Lymphoma (HGBCL)

Primary Mediastinal B-cell Lymphoma (PMBCL)

Transformed Lymphoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

zamtocabtagene autoleucel (MB-CART2019.1)

Cyclophosphamide

Fludarabine

Bendamustine

A Research Study to Advance the CF Therapeutics Pipeline for People Without ModulatorsA Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators

Recruiting

Sponsor:

Nicole Hamblett

Location:

Omaha NE, Kansas City KS, Minneapolis MN, Saint Louis MOshow 58 more

Code:

NCT06504589

Conditions

Cystic Fibrosis

Eligibility Criteria

Sex: All

Age: 12+

Healthy Volunteers: Not accepted

To Evaluate Efficacy and Safety of Serplulimab + Chemotherapy (Carboplatin- Etoposide) in US Patients With ES-SCLCTo Evaluate Efficacy and Safety of Serplulimab + Chemotherapy (Carboplatin- Etoposide) in US Patients With ES-SCLC

Recruiting

PHASE3

Sponsor:

Shanghai Henlius Biotech

Location:

Omaha NE, Lincoln NE, Kansas City MO, Wichita KSshow 85 more

Code:

NCT05468489

Conditions

Extensive Stage Small Cell Lung Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Serplulimab + chemotherapy (carboplatin-etoposide)

Atezolizumab + chemotherapy (carboplatin-etoposide)

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Recruiting

PHASE3

Sponsor:

NRG Oncology

Location:

Bellevue NE, Papillion NE, Omaha NE, Council Bluffs IAshow 706 more

Code:

NCT05879926

Conditions

Breast Cancer

Eligibility Criteria

Sex: Female

Age: 18 - 60

Healthy Volunteers: Not accepted

Interventions

Ovarian Function Suppression + Aromatase Inhibitor

Adjuvant Chemotherapy + Ovarian Function Suppression

Measuring Outcomes of LASIK and EVO-ICL in Matched PopulationsMeasuring Outcomes of LASIK and EVO-ICL in Matched Populations

Recruiting

Sponsor:

Vance Thompson Vision

Location:

Omaha NE, Sioux Falls SD, Cleveland OH, Houston TXshow 1 more

Code:

NCT06700460

Conditions

Myopia

Eligibility Criteria

Sex: All

Age: 21 - 45

Healthy Volunteers: Not accepted

Interventions

Laser-assisted in Situ Keratomileusis

Implantable Collamer Lens placement

A Study of Sotatercept for the Treatment of Cpc-PH Due to HFpEF (MK-7962-007/A011-16)A Study of Sotatercept for the Treatment of Cpc-PH Due to HFpEF (MK-7962-007/A011-16)

Recruiting

PHASE2

Sponsor:

Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA

Location:

Omaha NE, Kansas City KS, Iowa City IA, Minneapolis MNshow 49 more

Code:

NCT04945460

Conditions

Hypertension, Pulmonary

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Sotatercept 0.3 mg/kg

Placebo

Sotatercept 0.3 mg/kg escalating to 0.7 mg/kg

Study of RYZ101 in Combination With SoC in Subjects With SSTR+ ES-SCLCStudy of RYZ101 in Combination With SoC in Subjects With SSTR+ ES-SCLC

Recruiting

PHASE1

Sponsor:

RayzeBio, Inc.

Location:

Omaha NE, Rochester MN, Grand Rapids MI, Troy MIshow 6 more

Code:

NCT05595460

Conditions

SCLC,Extensive Stage

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

RYZ101 Dose Level 1

RYZ101 Dose Level 2

RYZ101 Dose Level 3

RYZ101 Dose Level -1

Atezolizumab